Evaluation of the QUANTUM BLUE sCAL rapid test as a point of care tool to identify patients with peritonsillar abscess

Abstract S100A8/A9 (Calprotectin) serves as a biomarker for various inflammatory diseases, such as for peritonsillar abscess (PTA). Recently, the PTA score was developed for reliable PTA identification. It uses a combination of characteristic clinical symptoms and elevated calprotectin levels in ser...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lea-Sophie Stahl, Johannes Roth, Claudia Rudack, Annika McNally, Jakob Weber, Thomas Vogl, Christoph Spiekermann
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/304b82d88a6541e595d5d420364f36f0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:304b82d88a6541e595d5d420364f36f0
record_format	dspace
spelling	oai:doaj.org-article:304b82d88a6541e595d5d420364f36f02021-12-02T13:19:23ZEvaluation of the QUANTUM BLUE sCAL rapid test as a point of care tool to identify patients with peritonsillar abscess10.1038/s41598-021-84027-w2045-2322https://doaj.org/article/304b82d88a6541e595d5d420364f36f02021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-84027-whttps://doaj.org/toc/2045-2322Abstract S100A8/A9 (Calprotectin) serves as a biomarker for various inflammatory diseases, such as for peritonsillar abscess (PTA). Recently, the PTA score was developed for reliable PTA identification. It uses a combination of characteristic clinical symptoms and elevated calprotectin levels in serum and saliva to determine this score. Although well-established point-of-care tests (POCT) to determine serum or faecal calprotectin levels exist, a reliable and rapid tool to analyse salivary calprotectin has not yet been described. In this study, we analysed the potential of the QUANTUM BLUE sCAL Test (QBT, BÜHLMANN Laboratories AG, Switzerland) to determine S100A8/A9 levels during outpatient management. These QBT measurements are combined with other clinical factors to determine the PTA score. Significantly higher calprotectin levels were determined by QBT in patients with PTA compared to healthy controls. The receiver operating characteristic (ROC) curves for the QBT revealed cut-off values of 2940 ng/ml (sensitivity = 0.88, specificity = 0.78) in serum and 5310 ng/ml (sensitivity = 0.80, specificity = 0.50) in saliva. By adding the QBT results to determine PTA values, a ROC analysis provided a statistical cut-off score of 2.5 points to identify the existence of a PTA with a sensitivity of 100% and a specificity of 89.3%. The QUANTUM BLUE sCAL Test (QBT) is an appropriate POCT to determine serum and salivary calprotectin levels. Thus, PTA scores can be determined within a short time frame by applying the QBT during outpatient management.Lea-Sophie StahlJohannes RothClaudia RudackAnnika McNallyJakob WeberThomas VoglChristoph SpiekermannNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Lea-Sophie Stahl Johannes Roth Claudia Rudack Annika McNally Jakob Weber Thomas Vogl Christoph Spiekermann Evaluation of the QUANTUM BLUE sCAL rapid test as a point of care tool to identify patients with peritonsillar abscess
description	Abstract S100A8/A9 (Calprotectin) serves as a biomarker for various inflammatory diseases, such as for peritonsillar abscess (PTA). Recently, the PTA score was developed for reliable PTA identification. It uses a combination of characteristic clinical symptoms and elevated calprotectin levels in serum and saliva to determine this score. Although well-established point-of-care tests (POCT) to determine serum or faecal calprotectin levels exist, a reliable and rapid tool to analyse salivary calprotectin has not yet been described. In this study, we analysed the potential of the QUANTUM BLUE sCAL Test (QBT, BÜHLMANN Laboratories AG, Switzerland) to determine S100A8/A9 levels during outpatient management. These QBT measurements are combined with other clinical factors to determine the PTA score. Significantly higher calprotectin levels were determined by QBT in patients with PTA compared to healthy controls. The receiver operating characteristic (ROC) curves for the QBT revealed cut-off values of 2940 ng/ml (sensitivity = 0.88, specificity = 0.78) in serum and 5310 ng/ml (sensitivity = 0.80, specificity = 0.50) in saliva. By adding the QBT results to determine PTA values, a ROC analysis provided a statistical cut-off score of 2.5 points to identify the existence of a PTA with a sensitivity of 100% and a specificity of 89.3%. The QUANTUM BLUE sCAL Test (QBT) is an appropriate POCT to determine serum and salivary calprotectin levels. Thus, PTA scores can be determined within a short time frame by applying the QBT during outpatient management.
format	article
author	Lea-Sophie Stahl Johannes Roth Claudia Rudack Annika McNally Jakob Weber Thomas Vogl Christoph Spiekermann
author_facet	Lea-Sophie Stahl Johannes Roth Claudia Rudack Annika McNally Jakob Weber Thomas Vogl Christoph Spiekermann
author_sort	Lea-Sophie Stahl
title	Evaluation of the QUANTUM BLUE sCAL rapid test as a point of care tool to identify patients with peritonsillar abscess
title_short	Evaluation of the QUANTUM BLUE sCAL rapid test as a point of care tool to identify patients with peritonsillar abscess
title_full	Evaluation of the QUANTUM BLUE sCAL rapid test as a point of care tool to identify patients with peritonsillar abscess
title_fullStr	Evaluation of the QUANTUM BLUE sCAL rapid test as a point of care tool to identify patients with peritonsillar abscess
title_full_unstemmed	Evaluation of the QUANTUM BLUE sCAL rapid test as a point of care tool to identify patients with peritonsillar abscess
title_sort	evaluation of the quantum blue scal rapid test as a point of care tool to identify patients with peritonsillar abscess
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/304b82d88a6541e595d5d420364f36f0
work_keys_str_mv	AT leasophiestahl evaluationofthequantumbluescalrapidtestasapointofcaretooltoidentifypatientswithperitonsillarabscess AT johannesroth evaluationofthequantumbluescalrapidtestasapointofcaretooltoidentifypatientswithperitonsillarabscess AT claudiarudack evaluationofthequantumbluescalrapidtestasapointofcaretooltoidentifypatientswithperitonsillarabscess AT annikamcnally evaluationofthequantumbluescalrapidtestasapointofcaretooltoidentifypatientswithperitonsillarabscess AT jakobweber evaluationofthequantumbluescalrapidtestasapointofcaretooltoidentifypatientswithperitonsillarabscess AT thomasvogl evaluationofthequantumbluescalrapidtestasapointofcaretooltoidentifypatientswithperitonsillarabscess AT christophspiekermann evaluationofthequantumbluescalrapidtestasapointofcaretooltoidentifypatientswithperitonsillarabscess
_version_	1718393261809205248

Evaluation of the QUANTUM BLUE sCAL rapid test as a point of care tool to identify patients with peritonsillar abscess

Ejemplares similares